ARID3A and systemic lupus erythematosus: We found that whole blood from SLE patients with increased numbers of ARID3a-expressing B cells showed decreased methylation of promoters for a number of Type I interferon genes, including IFNα2 and IFNα6, compared to SLE samples with normal levels of ARID3a-expressing B cells [38,42].